BioPlus Acquisition Corp.
BIOSDelisted Oct 6, 2023- Industry
- Electromedical & Electrotherapeutic Apparatus
- SEC CIK
- 0001856653
BioPlus Acquisition Corp. was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Jun 12, 2023; 30 institutions reported holding it in 13F filings for Q3 2023, worth $135.2M in total; no superinvestor held it.
Q1 2023 vs. Q4 2022
How the institutions holding BioPlus Acquisition Corp. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 66 | 1 | 61 | −4 |
| Shares | 20.8M | 66.6K | 22.1M | +1.36M (+6.6%) |
| Value | $213.3M | $685.0K | $230.7M | +$18.1M (+8.5%) |
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held BioPlus Acquisition Corp. at the end of Q1 2023 but not at the end of Q4 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Meteora Capital, LLC | 909,471 | $9.49M | 1.12% |
| UBS Oconnor LLC | 463,372 | $4.84M | 0.12% |
| Davidson Kempner Partners | 250,000 | $2.61M | 0.06% |
| Flow State Investments, L.P. | 117,359 | $1.23M | 1.01% |
| Clear Street LLC | 84,180 | $878.8K | 0.14% |
| StoneX Group Inc. | 42,600 | $444.7K | 0.05% |
Sold out (10)
Institutions that held BioPlus Acquisition Corp. at the end of Q4 2022 and filed for Q1 2023 without it.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Highbridge Capital Management LLC | 1,482,836 | $15.2M |
| Marshall Wace, LLP | 502,350 | $5.16M |
| Taconic Capital Advisors LP | 500,000 | $5.14M |
| Sculptor Capital LP | 500,100 | $5.11M |
| HSBC Holdings PLC | 145,000 | $1.49M |
| Spartan Fund Management Inc. | 74,485 | $763.0K |
| Sona Asset Management (US) LLC | 30,000 | $306.6K |
| Paloma Partners Management Co | 20,000 | $205.6K |
| UBS Group AG | 1,160 | $11.9K |
| Tower Research Capital LLC (TRC) | 92 | $1.00K |
Not filed for Q1 2023 yet (1)
Institutions that held BioPlus Acquisition Corp. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Telemetry Investments, L.L.C. | 66,607 | $685.0K |